Primary hyperaldosteronism
- Indications to test for mineralocorticoid excess in hypertensive patients include
- Hypokalaemia (including hypokalemia induced by thiazide diuretics),
- Poor control of blood pressure with conventional therapy,
- Family history of early-onset hypertension,
- Presentation at a young age.
Clinical features
- Usually asymptomatic
- Sodium retention → oedema, HTN
- Hypokalaemia:
- muscle weakness (even paralysis),
- polyuria (secondary to renal tubular damage, which produces nephrogenic DI)
- tetany (associated metabolic alkalosis and low ionized calcium).
Investigations:
Investigation | Finding |
Biochemical | |
S electrolytes, creatinine, ABG |
|
|
|
saline/ fludrocortisone suppression tests. | |
Imaging and localisation | |
CT or MRI abdomen
(adrenal protocol) |
|
Adrenal vein catheterisation with measurement of aldosterone |
|
Management
- Mineralocorticoid receptor antagonists
- spironolactone and eplerenone: correction of hypokalemia and hypertension
- spironolactone→ (20% of males) develop gynaecomastia → alternative→ Amiloride
- APA:
- Medical therapy is usually given for a few weeks to normalize whole-body electrolyte balance before unilateral adrenalectomy.
- Surgery cures the biochemical abnormality
- Hypertension may persist (70% of cases), probably because of irreversible damage to the systemic microcirculation